John R. Moore, General Counsel at Edgewise Therapeutics, Inc. (EWTX), sold 41,677 shares at $20.01 ($834K) on 2024-02-08, disclosed to the SEC on 2024-02-09.
Scheduled sale ($834k) by General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.00 | 17,993 | $360K | 43.2% |
| 2 | $20.01 | 3,813 | $76K | 9.2% |
| 3 | $20.01 | 3,813 | $76K | 9.2% |
| 4 | $20.01 | 8,029 | $161K | 19.3% |
| 5 | $20.01 | 8,029 | $161K | 19.3% |
| Total | $20.01 avg | 41,677 |
| $834K |
| 100% |
| Filing → |
| EWTX | SELL | 2025-05-07 | $32K | — | Filing → |
| EWTX | SELL | 2024-09-24 | $2.6M | — | Filing → |
| EWTX | SELL | 2024-05-03 | $37K | — | Filing → |